SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Consent Solicitation Early Consent Deadline

6 Feb 2018 07:00

RNS Number : 9809D
Nationwide Building Society
06 February 2018
 

 

Nationwide Building Society

(incorporated in England under the Building Societies Act 1986, as amended)

update regarding the consent solicitation and proposal to all holders (the Noteholders) of its outstanding

€750,000,000 6.75 per cent. Subordinated Notes due 22 July 2020 (ISIN: XS0527239221) (the Notes)

6 February 2018. On 25 January 2018, Nationwide Building Society (the Society) announced an invitation (the Consent Solicitation) to holders of the Notes to consent to the modification of the terms and conditions of the Notes (the Conditions) and the Trust Deed constituting the Notes, as proposed by the Society (the Proposal) for approval by an extraordinary resolution (an Extraordinary Resolution) at a meeting of the Noteholders (the Meeting), all as further described in the Consent Solicitation Memorandum prepared by the Society dated 25 January 2018 (the Consent Solicitation Memorandum). Capitalised terms used and not otherwise defined in this announcement have the meaning given in the Consent Solicitation Memorandum.

The Early Consent Deadline for the Consent Solicitation was 4.00 p.m. (London time) on 5 February 2018. As at the Early Consent Deadline, Solicitation Instructions had been received in respect of 79.31 per cent. of the aggregate principal amount of the Notes outstanding, of which 99.62 per cent. are instructions in favour of the Extraordinary Resolution.

Accordingly, subject to any revocation of Solicitation Instructions in the limited circumstances in which revocation is permitted as described in the Consent Solicitation Memorandum, the Meeting of Noteholders convened for 10.00 a.m. (London time) on 20 February 2018 will be quorate and the Extraordinary Resolution will be passed.

The Society will announce the results of the Meeting as soon as reasonably practicable after the Meeting.

Further details on the transaction can be obtained from:

THE SOLICITATION AGENTS

BNP Paribas

10 Harewood Avenue

London NW1 6AA

United Kingdom

 

Telephone: +44 20 7595 8668

Attention: Liability Management Group

Email: liability.management@bnpparibas.com

UBS Limited5 BroadgateLondon EC2M 2QSUnited Kingdom

 

Telephone: +44 20 7568 2133

Attention: Liability Management Group

Email: ol-liabilitymanagement-eu@ubs.com

 

Requests for documentation and information in relation to the procedures for delivering Solicitation Instructions should be directed to:

TABULATION AGENT

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

 

Telephone: +44 20 7704 0880

Attention: David Shilson / Arlind Bytyqi

Email: nationwide@lucid-is.com

Inside Information Notice

This announcement is released by Nationwide Building Society and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Alex Wall, Head of Capital, Ratings & Investor Relations of Nationwide Building Society.

DISCLAIMER: This announcement must be read in conjunction with the Consent Solicitation Memorandum. The Consent Solicitation Memorandum contains important information which should be read carefully before any decision is made with respect to the Consent Solicitation. If any Noteholder is in any doubt as to the action it should take or is unsure of the impact of the implementation of the Consent Solicitation or the Proposal, it is recommended to seek its own financial and legal advice, including in respect of any tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to participate in the Consent Solicitation or otherwise participate in the Proposal. None of the Society, the Solicitation Agents, the Tabulation Agent, the Trustee or the Principal Paying Agent makes any recommendation whether Noteholders should participate in the Consent Solicitation or otherwise participate in the Proposal.

Nothing in this announcement or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to purchase or sell any security in any jurisdiction. The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law, and persons into whose possession this announcement or the Consent Solicitation Memorandum comes are requested to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUAPUPRGBA
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.